Health Science Campus
Dowling Hall, Basement, Room 80
website address: cme.utoledo.eduEmail: ContinuingMeded@utoledo.edu
Title: Anticoagulation Safety and National patient Safety Goal 3E
Presenter: Todd Gundrum, PharmD, BCPS, Clinical Pharmacist, UTMC
Release Date: December 18, 2009
Termination Date: December 17, 2012
Target Audience: UTMC Physicians, nurses, physician assistants, pharmacists
Educational Objectives: Upon completion of this activity, the participant should be able to:
1. Discuss National Patient Safety Goal 3E.
2. Identify important information relating to Heparin usage.
3. Recognize important information relating to LMWH and fondaparinux usage.
4. Describe important aspects of warfarin usage.
5. Discuss the role of patient/family education relating to NPSG 3E.
6. Identify key actions relating to deep vein thrombosis prevention.
Presenter, Todd Gundrum does not have any financial interest or other relationship with any manufacturer of commercial product or service to disclose.
Reviewer, Mary R. Smith, M.D. does not have any financial interest or other relationship with any manufacturer of commercial product or service to disclose.
Planning committee members (Mary R. Smith, M.D.; Marge McFadden, RN, MSN NE-BC; Todd Gundrum PharmD, BCPS; nor Dawn Durivage) have no financial interest or other relationships with any manufacturer of commercial product or service to disclose.
Presentation: Please review the presentation, then submit the required documentation. http://electure.utoledo.edu:8080/ess/echo/presentation/50485534-6a04-40c8-93c2-12c8a49b9db3
Required Documentation: In order to received continuing education credit, you must print BOTH the Evaluation Form and Test documents below and mail as noted on the Evaluation Form.
NPSG 3E Test Questions (Must correctly answer 7 out of 9 questions)
The University of Toledo is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Toledo designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The University of Toledo Medical Center is an approved provider of continuing education for pharmacists by the Ohio State Board of Pharmacy. This program has been designated for 0.1 CEU with identification number 036-142-10-05-H01. Each pharmacists should claim only those hours of credit that he/she actually spent in the educational activity.